OR WAIT null SECS
April 24, 2023
The Supreme Court’s action leaves open the prospect of further rulings that could undermine FDA’s approval process.
April 21, 2023
A report from Business Standard highlighted India’s recent growth in the pharma sector.
April 20, 2023
GSK has reached an agreement to acquire late-stage biopharmaceutical company BELLUS Health.
SAB Biotherapeutics has received both breakthrough and fast track designations from FDA for its lead antibody drug candidate for treating influenza.
April 18, 2023
Jaeger notes that the program is focused on addressing specific scientific questions that will produce immediate impacts on how CDER and FDA make drug approval decisions.
Moderna and Merck reported that a combination therapy involving pembrolizumab and an mRNA demonstrated a 44% reduction in recurrence or death in cancer patients compared to non-combination treatments.
AbbVie’s RINVOQ has received European Commission approval for the treatment of moderately to severely active Crohn’s disease.
Gamida Cell’s therapy is meant to reduce the risk of infection following stem cell transplantation.
Integrated systems combine functions.
April 14, 2023
Under this partnership, the two companies will develop bioprinted tissue therapeutics for diabetes and obesity.